Filtros de búsqueda

Lista de obras de Massimo Di Maio

153Sm: its use in multiple myeloma and report of a clinical experience

artículo científico publicado en 2008

A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy

artículo científico publicado en 2014

A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer.

artículo científico publicado en 2011

A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and G

article

A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.

artículo científico publicado en 2009

A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study.

artículo científico publicado en 2004

A randomized phase II study of pemetrexed or RAD001 as second-line treatment of advanced non-small-cell lung cancer in elderly patients: treatment rationale and protocol dynamics.

artículo científico publicado en 2007

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

scientific article published on 16 September 2020

Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.

artículo científico

Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treat

artículo científico publicado en 2015

Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives

artículo científico

Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence.

artículo científico publicado en 2011

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.

artículo científico publicado en 2016

BRAF-mutated metastatic colorectal cancer between past and future.

artículo científico publicado en 2015

Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study

scientific article published on 12 March 2012

Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion

scientific article published on 01 March 2020

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

artículo científico publicado en 2014

Carboplatin plus paclitaxel scheduling for advanced ovarian cancer - authors' reply

artículo científico publicado en 2014

Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial

artículo científico publicado en 2011

Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data

artículo científico publicado en 2012

Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials.

artículo científico publicado en 2010

Cetuximab in non-small-cell lung cancer

Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly

artículo científico publicado en 2006

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.

artículo científico publicado en 2005

Chemotherapy-induced neutropenia: a useful predictor of treatment efficacy?

artículo científico publicado en 2006

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Tr

artículo científico publicado en 2014

Clinical and organizational issues in the management of surviving breast and colorectal cancer patients: attitudes and feelings of medical oncologists

artículo científico publicado en 2014

Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials

artículo científico publicado en 2010

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines.

artículo científico publicado en 2010

Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better….

artículo científico

Complete resolution of psoriasis in a patient treated with stealth liposomal doxorubicin and carboplatin for ovarian cancer

scientific article published on 20 July 2004

Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma

artículo científico publicado en 2016

Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience

scientific article published on 10 August 2020

Endoscopic surveillance for hereditary non-polyposis colorectal cancer (HNPCC) family members in a Southern Italian region.

artículo científico publicado en 2010

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions

artículo científico publicado en 2018

Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review

scientific article published on 09 September 2020

Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study

artículo científico publicado en 2020

Factorial design for randomized clinical trials

artículo científico publicado en 2006

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial

artículo científico publicado en 2012

Gefitinib in non small cell lung cancer

artículo científico publicado en 2011

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)

article

Hormonal treatment of human hepatocellular carcinoma.

artículo científico publicado en 2006

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives.

artículo científico publicado en 2017

Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).

artículo científico publicado en 2013

Incidence and pathological characteristics of prostate cancer in Italy: a contribution to the screening debate

artículo científico publicado en 2006

Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer

artículo científico publicado en 2007

Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer

artículo científico publicado en 2013

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial.

artículo científico publicado en 2006

Is flexible bronchoscopy necessary to confirm the position of double-lumen tubes before thoracic surgery?

artículo científico publicado en 2011

Is human hepatocellular carcinoma a hormone-responsive tumor?

artículo científico publicado en 2008

Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer.

artículo científico publicado en 2011

Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA)

article

LUX-Lung: determining the best EGFR inhibitor in NSCLC?

artículo científico publicado en 2015

Lessons from clinical trials on quality-of-life assessment in ovarian cancer trials.

artículo científico publicado en 2016

Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis.

artículo científico publicado en 2010

Maintenance therapy in NSCLC: why? To whom? Which agent? ⬇️

artículo científico publicado en 2011

Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

artículo científico publicado en 2005

Medical treatment of resistant or recurrent epithelial ovarian cancer

scientific article published on 01 June 2006

Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer

artículo científico publicado en 2009

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM).

artículo científico publicado en 2016

Molecular markers to predict response to gefitinib: EGFR, ErbB-2, or more?

artículo científico publicado en 2004

New drugs in advanced non-small-cell lung cancer: searching for the correct clinical development

artículo científico publicado en 2010

Outcome of patients with a performance status of 2 in the Multicenter Italian Lung Cancer in the Elderly Study (MILES)

scientific article published on 01 December 2004

Palonosetron: more than just another option?

artículo científico publicado en 2009

Papillary renal cell carcinoma: A review of the current therapeutic landscape

artículo científico

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

artículo científico publicado en 2015

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

artículo científico publicado en 2014

Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial

artículo científico publicado en 2012

Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles

artículo científico publicado en 2016

Potentiality and boundaries of use of sorafenib in patients with hepatocellular carcinoma: awaiting the results of ongoing clinical trials.

artículo científico publicado en 2012

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients

artículo científico publicado en 2015

Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials.

artículo científico

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

artículo científico publicado en 2015

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

artículo científico publicado en 2012

Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxel

artículo científico publicado en 2012

Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer

artículo científico publicado en 2014

Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter?

artículo científico publicado en 2008

Prophylactic cranial irradiation in extensive disease small cell lung cancer: An endless debate

artículo científico publicado en 2019

Quality of Life in elderly patients with cancer

artículo científico publicado en 2003

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer

artículo científico publicado en 2012

Raising the bar for enthusiasm when looking at results of randomized phase II trials-the case of sunitinib in small-cell lung cancer.

artículo científico publicado en 2016

Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence

artículo científico publicado en 2020

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study

artículo científico publicado en 2013

Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study

artículo científico publicado en 2010

Re: Design and endpoints of clinical trials in hepatocellular carcinoma

artículo científico publicado en 2008

Registrative trials of antiemetic drugs: arrival or starting point?

artículo científico publicado en 2009

Reply to P. Baldo et al

artículo científico publicado en 2015

Reply to the letter to the editor 'On the underreporting of health-related quality of life and regulatory approval' by Bhamidipati et al

scientific article published on 01 April 2019

Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.

artículo científico publicado en 2016

Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel

artículo científico publicado en 2007

Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial

artículo científico publicado en 2006

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data

artículo científico publicado en 2014

Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer.

artículo científico publicado en 2016

State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough

artículo científico publicado en 2019

Statistical design in phase II clinical trials and its application in breast cancer.

artículo científico publicado en 2003

Subgroup Analysis: Refining a Positive Result or Trying to Rescue a Negative One?

scientific article published on 21 September 2015

Supportive care in patients with advanced non-small-cell lung cancer.

artículo científico publicado en 2003

Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients

artículo científico publicado en 2012

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

artículo científico publicado en 2015

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

artículo científico publicado en 2016

Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma.

artículo científico publicado en 2006

Targeted therapies: Role of sorafenib in HCC patients with compromised liver function.

artículo científico publicado en 2009

Targeting targeted agents: open issues for clinical trial design

artículo científico publicado en 2009

The ICET-A Survey on Current Criteria Used by Clinicians for the Assessment of Central Adrenal Insufficiency in Thalassemia: Analysis of Results and Recommendations

artículo científico publicado en 2016

The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations

artículo científico publicado en 2016

The impact of chemotherapy-induced nausea and vomiting on health-related quality of life.

artículo científico publicado en 2006

The impact of decreasing cutoff values for maximal oxygen consumption (VO(2)max) in the decision-making process for candidates to lung cancer surgery

artículo científico publicado en 2013

The lesson learned from figitumumab clinical program and the hope for better results in squamous lung cancer.

artículo científico publicado en 2015

The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.

artículo científico publicado en 2004

Time spent for activation of non-profit studies in oncology in Italy

artículo científico publicado en 2010

Time trend in treatment-related deaths of patients with advanced non-small-cell lung cancer enrolled into phase III trials of systemic treatment.

artículo científico publicado en 2010

Tivantinib added to erlotinib in nonsmall-cell lung cancer: the primary end point was not MET....

artículo científico publicado en 2015

Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database.

artículo científico publicado en 2014

Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?

artículo científico publicado en 2009

Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

artículo científico

Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel.

artículo científico publicado en 2004

Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic Oncology

artículo científico publicado en 2013

Treatment of small cell lung cancer

scholarly article by Alessandro Morabito et al published September 2014 in Critical Reviews in Oncology Hematology

TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study

artículo científico publicado en 2021

Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

artículo científico publicado en 2005

Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?

artículo científico publicado en 2009

Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions.

artículo científico publicado en 2006

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer

artículo científico

Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature

artículo científico publicado en 2015

Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study

artículo científico publicado en 2011

Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions.

scientific article published on 06 April 2009

Vandetanib: An overview of its clinical development in NSCLC and other tumors.

artículo científico publicado en 2010

Vinorelbine for non-small cell lung cancer.

artículo científico publicado en 2010

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial.

artículo científico publicado en 2014

[Cancer on the big screen. How and when movies deal with oncological diseases]

artículo científico publicado en 2014

management of nonhematologic toxicities associated with different EGFR-TKIs in advanced NSCLC: a comparison analysis.

artículo científico publicado en 2014

p53 expression is decreased in primary breast carcinomas with microsatellite instability

scientific article published on 01 June 2002

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda